418 related articles for article (PubMed ID: 28083606)
21. Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.
Garrido-Rodríguez D; Ávila-Ríos S; García-Morales C; Valenzuela-Ponce H; Ormsby C; Reyes-Gopar H; Fernandez-Lopez JC; Reyes-Terán G
Immunogenetics; 2016 Oct; 68(9):703-17. PubMed ID: 27240860
[TBL] [Abstract][Full Text] [Related]
22. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
[TBL] [Abstract][Full Text] [Related]
23. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
24. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
25. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
[TBL] [Abstract][Full Text] [Related]
26. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
28. KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans.
Mhandire K; Zijenah LS; Tshabalala M; Yindom LM; Mlambo T; Mhandire DZ; Musarurwa C; Duri K; Rowland-Jones S; Dandara C; Stray-Pedersen B
OMICS; 2019 Feb; 23(2):111-118. PubMed ID: 30614763
[TBL] [Abstract][Full Text] [Related]
29. Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
Jelcić I; Hsu KC; Kakalacheva K; Breiden P; Dupont B; Uhrberg M; Martin R; Münz C; Lünemann JD
Mult Scler; 2012 Jul; 18(7):951-8. PubMed ID: 22185807
[TBL] [Abstract][Full Text] [Related]
30. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis.
Sun HS; Liu DX; Bai YY; Hu NW
Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119
[TBL] [Abstract][Full Text] [Related]
31. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
32. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
[TBL] [Abstract][Full Text] [Related]
33. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
34. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.
Díaz-Peña R; Vidal-Castiñeira JR; Moro-García MA; Alonso-Arias R; Castro-Santos P
Hum Immunol; 2016 Jan; 77(1):104-109. PubMed ID: 26542067
[TBL] [Abstract][Full Text] [Related]
35. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
[TBL] [Abstract][Full Text] [Related]
36. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G
J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478
[TBL] [Abstract][Full Text] [Related]
37. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
[TBL] [Abstract][Full Text] [Related]
38. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Venstrom JM; Zheng J; Noor N; Danis KE; Yeh AW; Cheung IY; Dupont B; O'Reilly RJ; Cheung NK; Hsu KC
Clin Cancer Res; 2009 Dec; 15(23):7330-4. PubMed ID: 19934297
[TBL] [Abstract][Full Text] [Related]
39. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
[TBL] [Abstract][Full Text] [Related]
40. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.
Jones DC; Edgar RS; Ahmad T; Cummings JR; Jewell DP; Trowsdale J; Young NT
Genes Immun; 2006 Oct; 7(7):576-82. PubMed ID: 16929347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
